AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
COLORECTAL-CANCER
Authors: AUDISIO RA DEBRAUD F WILS J
Citation: Ra. Audisio et al., COLORECTAL-CANCER, Critical reviews in oncology/hematology, 27(2), 1998, pp. 139-141
GASTRIC-CANCER
Authors: AUDISIO RA DEBRAUD F WILS J
Citation: Ra. Audisio et al., GASTRIC-CANCER, Critical reviews in oncology/hematology, 27(2), 1998, pp. 143-144
CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY
Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
2 PAN-EUROPEAN TRIALS IN ADJUVANT COLON-CANCER (PETACC-1-AND-2) - THEEFFICACY OF TOMUDEX(R) COMPARED TO BOLUS 5-FLUOROURACIL LEUCOVORIN (5-FU/LV) AND HIGH-DOSE INFUSIONAL 5-FU COMPARED TO BOLUS 5-FU/LV, IN PATIENTS WITH STAGE-III COLON-CANCER/
Authors: WILS J
Citation: J. Wils, 2 PAN-EUROPEAN TRIALS IN ADJUVANT COLON-CANCER (PETACC-1-AND-2) - THEEFFICACY OF TOMUDEX(R) COMPARED TO BOLUS 5-FLUOROURACIL LEUCOVORIN (5-FU/LV) AND HIGH-DOSE INFUSIONAL 5-FU COMPARED TO BOLUS 5-FU/LV, IN PATIENTS WITH STAGE-III COLON-CANCER/, Annals of oncology, 9, 1998, pp. 211-211
EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL
Authors: GRIMALDI C BLEIBERG H GAY F MESSNER M ROUGIER P KOK TC CIRERA L CERVANTES A DEGREVE J PAILLOT B BUSET M NITTI D SAHMOUD T DUEZ N WILS J
Citation: C. Grimaldi et al., EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 411-417
FIRST-LINE CHEMOTHERAPY FOR COLORECTAL-CARCINOMA - WE ARE MAKING PROGRESS
Authors: KOHNE CH KRETZSCHMAR A WILS J
Citation: Ch. Kohne et al., FIRST-LINE CHEMOTHERAPY FOR COLORECTAL-CARCINOMA - WE ARE MAKING PROGRESS, Onkologie, 21(4), 1998, pp. 280-289
EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG
Authors: WILS J SAHMOUD T SOBRERO A BLEIBERG H AHMEDZAI S BLAZEBY J BLIJHAM G CONROY T CUNNINGHAM D CURRAN D DIAZRUBIO E DUCREUX M EVANS J GLIMELIUS B HUTCHINSON G KERR D KIEBERT G KOHNE H LABIANCA R LANGENDIJK R NITTI D NORDLINGER B ROUGIER P SCHEITHAUER W SCHMOLL HJ VANCUTSEM E WAGENER T WILKE J MARINUS A THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: ROUGIER P VANCUTSEM E BAJETTA E NIEDERLE N POSSINGER K LABIANCA R NAVARRO M MORANT R BLEIBERG H WILS J AWAD L HERAIT P JACQUES C
Citation: P. Rougier et al., RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1407-1412
ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL
Authors: ROUGIER P SAHMOUD T NITTI D CURRAN D DOCI R DEWAELE B NAKAJIMA T RAUSCHECKER H LABIANCA R PECTOR JC MARSONI S APOLONE G LASSER P COUVREUR ML WILS J
Citation: P. Rougier et al., ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL, Lancet, 351(9117), 1998, pp. 1677-1681
INITIAL HIGH ANTIEMETIC EFFICACY OF GRANISETRON WITH DEXAMETHASONE ISNOT MAINTAINED OVER REPEATED CYCLES
Authors: DEWIT R VANDENBERG H BURGHOUTS J NORTIER J SLEE P RODENBURG C KEIZER J FONTEYN M VERWEIJ J WILS J
Citation: R. Dewit et al., INITIAL HIGH ANTIEMETIC EFFICACY OF GRANISETRON WITH DEXAMETHASONE ISNOT MAINTAINED OVER REPEATED CYCLES, British Journal of Cancer, 77(9), 1998, pp. 1487-1491
THE ESTABLISHMENT OF A LARGE COLLABORATIVE TRIAL PROGRAM IN THE ADJUVANT TREATMENT OF COLON-CANCER
Authors: WILS J
Citation: J. Wils, THE ESTABLISHMENT OF A LARGE COLLABORATIVE TRIAL PROGRAM IN THE ADJUVANT TREATMENT OF COLON-CANCER, British Journal of Cancer, 77, 1998, pp. 23-28
FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL ON ADJUVANT INTRAPORTAL INFUSION WITH HEPARIN AND 5-FLUOROURACIL (5-FU) IN RESECTABLE COLON-CANCER (EORTC GITCCG 1983-1987)
Authors: NITTI D WILS J SAHMOUD T CURRAN D COUVREUR ML LISE M RAUSCHECKER H DOSSANTOS JG STREMMEL W ROELOFSEN F
Citation: D. Nitti et al., FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL ON ADJUVANT INTRAPORTAL INFUSION WITH HEPARIN AND 5-FLUOROURACIL (5-FU) IN RESECTABLE COLON-CANCER (EORTC GITCCG 1983-1987), European journal of cancer, 33(8), 1997, pp. 1209-1215
THE IDENTIFICATION OF HIGH-RISK PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: SAHMOUD T GRABOWSKA E BLIJHAM G KOHNE CH COUVREUR ML CURRAN D WILS J
Citation: T. Sahmoud et al., THE IDENTIFICATION OF HIGH-RISK PATIENTS WITH METASTATIC COLORECTAL-CANCER, European journal of cancer, 33, 1997, pp. 741-741
RADIOTHERAPY AND 5-FU AFTER CURATIVE RESECTION FOR THE CANCER OF THE PANCREAS AND PERI-AMPULLARY REGION - A PHASE-III TRIAL OF THE EORTC GITCCG
Authors: KLINKENBIJL JHG SAHMOUD T VANPEL R COUVREUR ML VEENHOF CHN ARNAUD JP HENNIPMAN A WILS J JEEKEL J
Citation: Jhg. Klinkenbijl et al., RADIOTHERAPY AND 5-FU AFTER CURATIVE RESECTION FOR THE CANCER OF THE PANCREAS AND PERI-AMPULLARY REGION - A PHASE-III TRIAL OF THE EORTC GITCCG, European journal of cancer, 33, 1997, pp. 1239-1239
GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE
Authors: BLEIBERG H GERARD B WILS J BLIJHAM G DIAZRUBIO E HERRMANN R KERR D LABIANCA R ROUGIER P WILKE HJ WILKING N
Citation: H. Bleiberg et al., GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE, European journal of cancer, 33(10), 1997, pp. 1536-1545
IN DUTCH AND DANISH PATIENTS WITH FIGO-III OVARIAN-CARCINOMA, GEOGRAPHIC SURVIVAL DIFFERENCES ARE ASSOCIATED WITH DIFFERENCES IN QUANTITATIVE PATHOLOGICAL FEATURES
Authors: BRINKHUIS M BAAK JPA VANDIEST PJ LUND B WILS J
Citation: M. Brinkhuis et al., IN DUTCH AND DANISH PATIENTS WITH FIGO-III OVARIAN-CARCINOMA, GEOGRAPHIC SURVIVAL DIFFERENCES ARE ASSOCIATED WITH DIFFERENCES IN QUANTITATIVE PATHOLOGICAL FEATURES, International journal of gynecological cancer, 6(2), 1996, pp. 108-114
RESULTS OF A PHASE-II TRIAL OF EPIRUBICIN AND CISPLATIN (EP) BEFORE AND AFTER IRRADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER - AN EORTC GITCCG STUDY
Authors: WAGENER DJT HOOGENRAAD WJ ROUGIER P LUSINCHI A TAAL BG VEENHOF CHN DEGRAEFF A CONROY T CURRAN D SAHMOUD T WILS J
Citation: Djt. Wagener et al., RESULTS OF A PHASE-II TRIAL OF EPIRUBICIN AND CISPLATIN (EP) BEFORE AND AFTER IRRADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER - AN EORTC GITCCG STUDY, European journal of cancer, 32A(8), 1996, pp. 1310-1313
IS INTRAARTERIAL CHEMOTHERAPY WORTHWHILE IN THE TREATMENT OF PATIENTSWITH UNRESECTABLE HEPATIC COLORECTAL-CANCER METASTASES - CONTRA
Authors: KOHNE CH WILS J
Citation: Ch. Kohne et J. Wils, IS INTRAARTERIAL CHEMOTHERAPY WORTHWHILE IN THE TREATMENT OF PATIENTSWITH UNRESECTABLE HEPATIC COLORECTAL-CANCER METASTASES - CONTRA, European journal of cancer, 32A(13), 1996, pp. 2197-2201
TCNU IN COLORECTAL-CANCER - HOW MANY PATIENTS ARE NEEDED TO DEMONSTRATE THAT A DRUG DOESNT WORK
Authors: WILS J
Citation: J. Wils, TCNU IN COLORECTAL-CANCER - HOW MANY PATIENTS ARE NEEDED TO DEMONSTRATE THAT A DRUG DOESNT WORK, Annals of oncology, 7(2), 1996, pp. 211-211
MODULATION OF HIGH-DOSE INFUSIONAL FLUOROURACIL BY LOW-DOSE METHOTREXATE IN PATIENTS WITH ADVANCED OR METASTATIC COLORECTAL-CANCER - FINAL RESULTS OF A RANDOMIZED EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT OF-CANCER STUDY
Authors: BLIJHAM G WAGENER T WILS J DEGREVE J BUSET M BLEIBERG H LACAVE A DALMARK M SELLESLAG J COLLETTE L SAHMOUD T
Citation: G. Blijham et al., MODULATION OF HIGH-DOSE INFUSIONAL FLUOROURACIL BY LOW-DOSE METHOTREXATE IN PATIENTS WITH ADVANCED OR METASTATIC COLORECTAL-CANCER - FINAL RESULTS OF A RANDOMIZED EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT OF-CANCER STUDY, Journal of clinical oncology, 14(8), 1996, pp. 2266-2273
ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL VERSUS FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN PREMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE OPERABLE BREAST-CANCER - RESULTS OF A RANDOMIZED TRIAL
Authors: COOMBES RC BLISS JM WILS J MORVAN F ESPIE M AMADORI D GAMBROSIER P RICHARDS M AAPRO M VILLARGRIMALT A MCARDLE C PEREZLOPEZ FR VASSILOPOULOS P FERREIRA EP CHILVERS CED COOMBES G WOODS EM MARTY M
Citation: Rc. Coombes et al., ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL VERSUS FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN PREMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE OPERABLE BREAST-CANCER - RESULTS OF A RANDOMIZED TRIAL, Journal of clinical oncology, 14(1), 1996, pp. 35-45
PHASE-II TRIAL OF VINORELBINE IN METASTATIC SQUAMOUS-CELL ESOPHAGEAL-CARCINOMA
Authors: CONROY T ETIENNE PL ADENIS A WAGENER DJT PAILLOT B FRANCOIS E BEDENNE L JACOB JH SEITZ JF BLEIBERG H VANPOTTELSBERGHE C VANGLABBEKE M DELGADO FM MERLE S WILS J
Citation: T. Conroy et al., PHASE-II TRIAL OF VINORELBINE IN METASTATIC SQUAMOUS-CELL ESOPHAGEAL-CARCINOMA, Journal of clinical oncology, 14(1), 1996, pp. 164-170
ADJUVANT TREATMENT OF COLORECTAL-CANCER IN THE NETHERLANDS - A COMMENTARY
Authors: WILS J
Citation: J. Wils, ADJUVANT TREATMENT OF COLORECTAL-CANCER IN THE NETHERLANDS - A COMMENTARY, Netherlands journal of medicine, 49(1), 1996, pp. 52-53
ADVANCED GASTRIC-CANCER - COMPARISON OF FAMTX (5-FU, ADRIAMYCINE, METHOTREXATE) VERSUS ELF (ETROPOSIDE, 5-FU, LEUCOVORIN) VERSUS FUP (INFUSIONAL 5-FU PLUS CISPLATIN) - RESULTS FROM AN EORTC TRIAL OF THE GITCCGAND THE ARBEITSGEMEINSCHAFT FUR INNERE ONKOLOGIE (AIO)
Authors: ROUGIER P WILS J WILKE H LACAVE A VANCUTSEM E VANHOFER U SAHMOUD T CURRAN D MARINUS A
Citation: P. Rougier et al., ADVANCED GASTRIC-CANCER - COMPARISON OF FAMTX (5-FU, ADRIAMYCINE, METHOTREXATE) VERSUS ELF (ETROPOSIDE, 5-FU, LEUCOVORIN) VERSUS FUP (INFUSIONAL 5-FU PLUS CISPLATIN) - RESULTS FROM AN EORTC TRIAL OF THE GITCCGAND THE ARBEITSGEMEINSCHAFT FUR INNERE ONKOLOGIE (AIO), European journal of cancer, 31A, 1995, pp. 546-546
ADJUVANT CHEMO-HORMONAL THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN AND 5-FLUOROURACIL (CAF) WITH OR WITHOUT MEDROXYPROGESTERONE ACETATE FORNODE-POSITIVE CANCER-PATIENTS - UPDATE AT 7-YEAR FOLLOW-UP
Authors: HUPPERETS P WILS J VOLOVICS L SCHOUTEN L FICKERS M BRON H SCHOUTEN H JAGER J DEJONG J BEEX L HILLEN H BLIJHAM G
Citation: P. Hupperets et al., ADJUVANT CHEMO-HORMONAL THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN AND 5-FLUOROURACIL (CAF) WITH OR WITHOUT MEDROXYPROGESTERONE ACETATE FORNODE-POSITIVE CANCER-PATIENTS - UPDATE AT 7-YEAR FOLLOW-UP, Annals of oncology, 6(1), 1995, pp. 90-91
Risultati: 1-25 | 26-37